首页>
外国专利>
Use of a controlled release dosage form comprising an opioid agonist and an antagonist opoide in a controlled release Matrix which contains at least a Hydrophobic PolymerAnd at least a Fatty alcohol or fatty acid to prevent the formation of an excerpt of This formulation.
Use of a controlled release dosage form comprising an opioid agonist and an antagonist opoide in a controlled release Matrix which contains at least a Hydrophobic PolymerAnd at least a Fatty alcohol or fatty acid to prevent the formation of an excerpt of This formulation.
Controlled release dosage form comprising a controlled release Matrix of homogeneous comprising a Hydrophobic material.At least a Hydrophobic Polymer and at least one Fatty alcohol or Fatty Acid, an opioid agonist and an opioid antagonist.
展开▼